Antibody Therapeutics

eISSN: 2516-4236
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
5
SJR
Q3Immunology
4
Time to Publish
time-to-publish View Chart
4  Mo

Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
  • Publisher
    Oxford University Press
  • Language
    English
  • Article Processing Charges
    GBP 1750 | USD 2625
  • Publication Time
    8
  • Editorial Review Process
    Blind peer review
General Details
  • Language
    English
  • Society/Institute/Sponsor
    Chinese Antibody Society
  • Website URL
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 5%
4-6 90%
7-9 5%
>9 0%

Topics Covered

Tumor microenvironment
Antibody-drug conjugate
Downstream processing
Blocking antibody
Augmented reality
Chimeric antigen receptor
Severe acute respiratory syndrome coronavirus
Neutralizing antibody
Angiotensin-converting enzyme
Human papillomavirus
Bispecific antibody
Antiserum
Pandemic
Human papillomavirus vaccination
Monoclonal antibody
Tumor targeting
Immune checkpoint inhibitors
Affinity maturation

Recently Published Papers

Year-wise Publication

FAQs

Who is the publisher of Antibody Therapeutics? Faqs

The publisher of Antibody Therapeutics is Oxford University Press.

How can I view the journal metrics of Antibody Therapeutics on editage? Faqs

For the Antibody Therapeutics metrics, please refer to the section above on the page.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Tumor microenvironment, Antibody-drug conjugate, Downstream processing, Blocking antibody, Augmented reality, Chimeric antigen receptor, Severe acute respiratory syndrome coronavirus, Neutralizing antibody, Angiotensin-converting enzyme, Human papillomavirus, Bispecific antibody, Antiserum, Pandemic, Human papillomavirus vaccination, Monoclonal antibody, Tumor targeting, Immune checkpoint inhibitors, Affinity maturation.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.